Due to health issues, this site is no longer maintained and will be shut down shortly. |
Bison Capital Acquisition Corp. does not have significant operations. It intends to acquire businesses or entities through share exchange, share reconstruction, amalgamation, assets purchase, and any other similar business combination. The company was founded in 2016 and is based in Beijing, China.
On 3/18/2022 the company announced a proposed merger with Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology.
$22.71 +12.63 (125.30%)
As of 07/29/2022 16:00:00 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.